Current Medicines for Malaria Including Resistance Issues

Malaria is an old disease and continues to be a major health problem in many countries. In spite of decrement in morbidity and mortality due to malaria, the transmission is still active throughout the world. Hence, appropriate treatment is needed to handle malaria in addition to preventive measures....

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmacology & pharmacotherapeutics 2020-07, Vol.11 (3), p.90-99
Main Authors: Nureye, Dejen, Salahaddin, Mohammed, Zewudie, Ameha
Format: Article
Language:English
Subjects:
Drug development
Drug therapy
Drugs
Health aspects
Infection
Malaria
Methylene blue
Pharmaceutical industry
Pyrimethamine
Tafenoquine
Tetracycline
Tetracyclines
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Malaria is an old disease and continues to be a major health problem in many countries. In spite of decrement in morbidity and mortality due to malaria, the transmission is still active throughout the world. Hence, appropriate treatment is needed to handle malaria in addition to preventive measures. However, unavailability of new drugs and the occurrence of resistant Plasmodium strains toward many conventional antimalarial drugs including artemisinins are the major obstacles in combating malaria infection. Thus, experts from all directions of our planet are in search of novel compounds, and many new chemical entities, such as artefenomel, ferroquine, KAE609, KAF156, DSM265, methylene blue, MMV39048, DDD107498, SJ733, and MMV253, have been under drug development process. While many agents are in the pipeline, most of them are not able to kill both gametocytes and hypnozoites.
ISSN:0976-500X
0976-5018
DOI:10.4103/jpp.JPP_23_20